Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Net income (loss)	$ 1,846,000,000	$ 1,592,000,000	$ 698,000,000
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities
Loss (gain) on disposal of businesses and assets	0	0	22,000,000
Depreciation and amortization	1,269,000,000	1,196,000,000	1,136,000,000
Deferred and prepaid income taxes	(70,000,000)	(1,000,000)	(63,000,000)
Stock-based compensation expense	266,000,000	233,000,000	220,000,000
Goodwill and other intangible asset impairment charges	386,000,000	58,000,000	132,000,000
Net loss (gain) on investments and notes receivable	79,000,000	59,000,000	1,000,000
Contingent consideration net expense (benefit)	(5,000,000)	58,000,000	35,000,000
Inventory step-up amortization	51,000,000	6,000,000	32,000,000
Debt extinguishment net charges	0	0	194,000,000
Other, net	74,000,000	73,000,000	125,000,000
Increase (decrease) in operating assets and liabilities, excluding purchase accounting:
Trade accounts receivable	(351,000,000)	(238,000,000)	(220,000,000)
Inventories	(228,000,000)	(660,000,000)	(321,000,000)
Other assets	(126,000,000)	10,000,000	(209,000,000)
Accounts payable, accrued expenses and other liabilities	243,000,000	118,000,000	(255,000,000)
Cash provided by (used for) operating activities	3,435,000,000	2,503,000,000	1,526,000,000
Investing Activities
Purchases of property, plant and equipment and internal use software	(790,000,000)	(711,000,000)	(588,000,000)
Proceeds from sale of property, plant and equipment	3,000,000	4,000,000	12,000,000
Payments for acquisitions of businesses, net of cash acquired	(4,640,000,000)	(1,811,000,000)	(1,542,000,000)
Payments for investments and acquisitions of certain technologies	(280,000,000)	(89,000,000)	(24,000,000)
Proceeds from disposal of certain businesses and assets	0	0	5,000,000
Proceeds from royalty rights	20,000,000	30,000,000	70,000,000
Proceeds from settlements of hedge contracts	0	2,000,000	56,000,000
Cash provided by (used for) investing activities	(5,687,000,000)	(2,574,000,000)	(2,011,000,000)
Financing Activities
Payment of contingent consideration previously established in purchase accounting	(131,000,000)	(39,000,000)	(335,000,000)
Payments for royalty rights	(26,000,000)	(50,000,000)	(75,000,000)
Payments for finance leases	(25,000,000)	0	0
Payments on short-term borrowings	(504,000,000)	0	(250,000,000)
Proceeds from short-term borrowings, net of debt issuance costs	24,000,000	0	0
Net increase (decrease) in commercial paper	187,000,000	(4,000,000)	(1,000,000)
Payments on long-term borrowings and debt extinguishment costs	0	0	(3,184,000,000)
Proceeds from long-term borrowings, net of debt issuance costs	2,145,000,000	0	3,270,000,000
Cash dividends paid on preferred stock	0	(28,000,000)	(55,000,000)
Cash used to net share settle employee equity awards	(87,000,000)	(56,000,000)	(53,000,000)
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans	230,000,000	182,000,000	136,000,000
Cash provided by (used for) financing activities	1,814,000,000	5,000,000	(548,000,000)
Effect of foreign exchange rates on cash	(11,000,000)	(4,000,000)	(9,000,000)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	(450,000,000)	(70,000,000)	(1,042,000,000)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	1,055,000,000	1,126,000,000	2,168,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	606,000,000	1,055,000,000	1,126,000,000
Supplemental Information
Cash paid for income taxes, net	656,000,000	512,000,000	662,000,000
Cash paid for interest	250,000,000	259,000,000	450,000,000
Fair value of contingent consideration recorded in purchase accounting	29,000,000	273,000,000	0
Non-cash impact of transferred royalty rights	(20,000,000)	(30,000,000)	(70,000,000)
Cash and cash equivalents	414,000,000	865,000,000	928,000,000
Restricted cash and restricted cash equivalents included in Other current assets	111,000,000	130,000,000	149,000,000
Restricted cash equivalents included in Other long-term assets	80,000,000	60,000,000	48,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 606,000,000	$ 1,055,000,000	$ 1,126,000,000